Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Papers
, 2026, 'Causal effects of multiple sclerosis therapies in left-truncated registry data', in Multiple Sclerosis Journal, SAGE Publications, pp. 1052 - 1068, http://dx.doi.org/10.1177/13524585261459943
, 2025, 'Study Design of Two Phase 1/2 Studies to Assess Safety and Efficacy of YTB323, an Autologous CD19-Directed CAR-T Cell Therapy, in Multiple Sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SPAIN, Barcelona, pp. 1162 - 1162, presented at 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), SPAIN, Barcelona, 24 September 2025 - 26 September 2025
, 2025, 'CHARACTERISATION OF IMMUNOMETABOLIC PROFILE AFTER AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEOPLE WITH MULTIPLE SCLEROSIS', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 44 - 44, presented at 51st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 30 March 2025 - 02 April 2025
, 2025, 'CLONAL HAEMATOPOIESIS IN PATIENTS WITH AUTOIMMUNE DISEASE UNDERGOING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 43 - 44, presented at 51st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), ELECTR NETWORK, 30 March 2025 - 02 April 2025
, 2025, 'Understanding the microbiome in autologous haemopoietic stem cell transplant for multiple sclerosis', in Frontiers in Immunology, http://dx.doi.org/10.3389/fimmu.2025.1590601
, 2025, '247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation', BMJ, pp. a76.3 - a7a77, presented at 247 Clinically silent MRI lesions in RRMS: prognostic impact and an emulated trial of disease modifying therapy escalation, http://dx.doi.org/10.1136/jnnp-2025-abn.247
, 2024, 'Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 1142 - 1143, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024
, 2024, 'Clinically silent MRI lesions are associated with subsequent relapses and disability worsening in treated people with RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 634 - 637, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024
, 2024, 'Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, DENMARK, Copenhagen, pp. 1193 - 1196, presented at 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), DENMARK, Copenhagen, 18 September 2024 - 20 September 2024
, 2024, 'BEAM/ATG OR CYCLOPHOSPHAMIDE/ATG AS CONDITIONING REGIMEN IN AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE SCLEROSIS: A RETROSPECTIVE ANALYSIS OF THE EBMT AUTOIMMUNE DISEASES WORKING PARTY', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, SCOTLAND, Glasgow, pp. 41 - 41, presented at 50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), SCOTLAND, Glasgow, 14 April 2024 - 17 April 2024
, 2024, 'LONG TERM PERSISTENCE OF T MEMORY STEM CELLS FOLLOWING AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MULTIPLE SCLEROSIS', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, SCOTLAND, Glasgow, pp. 192 - 193, presented at 50th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), SCOTLAND, Glasgow, 14 April 2024 - 17 April 2024
, 2024, '3133 Ocrelizumab and inflammatory bowel disease', in Poster Abstracts, BMJ Publishing Group Ltd, pp. A42.2 - A42, presented at ANZAN Annual Scientific Meeting 2024 Abstracts, http://dx.doi.org/10.1136/bmjno-2024-anzan.118
, 2023, 'The risk of secondary progressive multiple sclerosis is geographically determined but modifiable', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Perth, pp. 6 - 6, presented at Multiple Sclerosis Australia: Progress in MS Research Conference (MS), AUSTRALIA, Perth, 29 November 2023 - 01 December 2023
, 2023, 'EBV-specific T cells are enriched following Autologous Stem Cell Transplant for MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ITALY, Milan, pp. 41 - 41, presented at 9th Joint ECTRIMS-ACTRIMS meeting, ITALY, Milan, 11 October 2023 - 13 October 2023
, 2023, 'The production of new regulatory T cell clones is associated with clinical response following autologous haematopoietic stem cell transplant for multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ITALY, Milan, pp. 809 - 809, presented at 9th Joint ECTRIMS-ACTRIMS meeting, ITALY, Milan, 11 October 2023 - 13 October 2023
, 2023, 'AUTOLOGOUS STEM CELL TRANSPLANTATION FOR AUTOIMMUNE DISEASES AT ST VINCENTS HOSPITAL, SYDNEY-25 YEARS AND 159 PATIENTS: AN ANALYSIS OF DISEASE SPECIFIC OUTCOMES AND SAFETY', in BONE MARROW TRANSPLANTATION, SPRINGERNATURE, ELECTR NETWORK, pp. 37 - 38, presented at 49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, ELECTR NETWORK, 23 April 2023 - 26 April 2023
, 2023, '13 Autologous haematopoietic Stem cell transplantation for non-MS neuroimmunological disorders: a single centre experience', in Concurrent Session Abstracts, BMJ Publishing Group Ltd, pp. A6.3 - A6, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.14
, 2023, '5 AHSCT as immune reconstitution therapy for MS – resetting the immune system or depleting EBV reservoirs?', in Young Investigators Presentation Abstracts, BMJ Publishing Group Ltd, pp. A2.2 - A2, presented at ANZAN Annual Scientific Meeting 2023 Abstracts, http://dx.doi.org/10.1136/bmjno-2023-anzan.5
, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 20 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Long-term Immune Reconstitution after Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, pp. 29 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000939493200065&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 11 - 14, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540800020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Comparative effectiveness of autologous haematopoietic stem cell transplantation with immune reconstitution therapies in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 619 - 621, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540802298&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Effectiveness of autologous haematopoietic stem cell transplantation in comparison with natalizumab in progressive MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, NETHERLANDS, Amsterdam, pp. 953 - 954, presented at 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, NETHERLANDS, Amsterdam, 26 October 2022 - 28 October 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000866540803426&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Haematopoietic stem cell transplantation for Multiple Sclerosis results in deletion of auto-reactive public CD4+T-cell clones', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 20 - 20, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'Long-term Immune Reconstitution after Autologous Haematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Hobart, pp. 29 - 29, presented at MS Australia Progress in MS Research Scientific Conference, AUSTRALIA, Hobart, 04 April 2022 - 05 April 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000899138300064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, '2314 Extensive remodelling of the lymphocyte repertoire and deletion of autoreactive clones following AHSCT in MS', in Abstracts, BMJ Publishing Group Ltd, pp. A11.2 - A11, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.28
, 2022, '2459 Acute plexitis after AstraZeneca COVID-19 vaccination in two immunocompromised patients', in Abstracts, BMJ Publishing Group Ltd, pp. A67.2 - A67, presented at ANZAN Annual Scientific Meeting 2022 Abstracts, http://dx.doi.org/10.1136/bmjno-2022-anzan.183
, 2022, 'The Biolinked Registry: Connection Is the Key to Innovation', in TRANSFUSION, WILEY, pp. 167A - 167A
, 2019, 'Diversification of the T cell repertoire following AHSCT is underpinned by thymic derived naive T cells in patients with aggressive RRMS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Melbourne, pp. NP17 - NP17, presented at Conference of MS-Research-Australia, AUSTRALIA, Melbourne, 31 October 2019 - 01 November 2019
, 2019, 'Immune reconstitution following autologous haematopoietic stem cell transplantation for multiple sclerosis is driven by sustained thymic reactivation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, GERMANY, Frankfurt, pp. 32 - 33, presented at 45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), GERMANY, Frankfurt, 24 March 2019 - 27 March 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487707800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2018, 'Analysis of Immune Reconstitution by Multicolour Flow Cytometry in Multiple Sclerosis and Non-Autoimmune Patients Following Autologous Haematopoietic Stem Cell Transplantation', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, PORTUGAL, Lisbon, pp. 203 - 203, presented at 44th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), PORTUGAL, Lisbon, 18 March 2018 - 21 March 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000487702802073&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Advanced, Treatment Refractory Multiple Sclerosis (MS) - a Phase II Clinical Trial', in BLOOD, AMER SOC HEMATOLOGY, GA, Atlanta, presented at 59th Annual Meeting of the American-Society-of-Hematology (ASH), GA, Atlanta, 09 December 2017 - 12 December 2017
, 2017, 'Autologous haematopoietic stem cell transplantation (AHSCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): a phase II trial from St Vincent's Hospital, Sydney Australia', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, FRANCE, Paris, pp. 594 - 594, presented at 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), FRANCE, Paris, 25 October 2017 - 28 October 2017
, 2017, 'Autologous haematopoietic stem cell transplantation (aHSCT) in multiple sclerosis (MS) a phase II trial at St Vincent's Hospital, Sydney', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, MS Res Australia, Sydney, pp. NP6 - NP6, presented at Progress in MS Research Conference, AUSTRALIA, MS Res Australia, Sydney, 11 October 2017 - 13 October 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000414783200015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Histopathological neurosarcoidosis in response to disseminated seminoma with absence of central nervous system metastases', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS
, 2017, 'Autologous stem cell transplantation (ASCT) in relapse remitting (RR-MS) and secondary progressive multiple sclerosis (SP-MS): an Australian-based prospective phase II trial', in BONE MARROW TRANSPLANTATION, NATURE PUBLISHING GROUP, FRANCE, Marseille, pp. S43 - S44, presented at 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), FRANCE, Marseille, 26 March 2017 - 29 March 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424355300048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1